CVR 32770487Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)HørsholmFounded 1 Jan 2010
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about EXPRES2ION BIOTECHNOLOGIES ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
20
CVR registry, Aug 2026
-4 (-16.7%) over 12 months
Gross profit
-9.2M
DKK, annual report 2025
Result
-21.9M
DKK, annual report 2025
Equity
24M
DKK, annual report 2025
Expres2ion Biotech Holding AB100% of capital and votes, since 3 May 2016
Bent Ulrich Frandsensince 20 Dec 2019
100% of capital and votesclass A OG Bsince 3 May 2016
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 1629467525% to under 33.3% of capital and votesclass B16 May 2012 to 16 Dec 2015
CVR 1453837220% to under 25% of capital and votesclass A2 Jul 2010 to 25 Apr 2016
CVR 1853899725% to under 33.3% of capital and votesclass Bnotified 17 Dec 201516 May 2012 to 2 May 2016
CVR 3277305233.3% to under 50% of capital and votesclass A, Bnotified 17 Dec 201516 May 2012 to 2 May 2016
1 Danish company.
CVR 3873273033.3% to under 50% of capital and votes
Found by searching the CVR owner register (ejerregister) for EXPRES2ION BIOTECHNOLOGIES ApS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
18 Feb 2010 to 8 Nov 2026.
1 Jan 2010 to 8 Nov 2026.
Aug 2026, monthly: 20 employees, 18 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | No count | No count | 5 | 7 | 11 | 10 | 9 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 10 | 10 | 9 | 9 | 10 | 10 | 11 | 12 | 11 | 11 | 12 | 12 | 13 | 13 | 12 | 13 | 12 | 12 | 14 | 14 | 13 | 13 | 12 | 12 | 13 | 13 | 14 | 14 | 15 | 15 | 15 | 15 | 15 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 19 | 15 | 16 | 17 | 16 | 16 | 16 | 17 | 17 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 18 | 18 | 18 | 17 | 19 | 20 | 20 | 19 | 19 | 18 | 21 | 25 | 25 | 30 | 30 | 30 | 30 | 30 | 34 | 33 | 34 | 32 | 31 | 35 | 36 | 36 | 36 | 35 | 34 | 33 | 34 | 33 | 33 | 35 | 35 | 35 | 36 | 33 | 34 | 32 | 30 | 28 | 26 | 22 | 22 | 22 | 21 | 21 | 21 | 21 | 21 | 22 | 23 | 24 | 23 | 23 | 22 | 21 | 23 | 24 | 24 | 25 | 24 | 25 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | 24 | 24 | 19 | 20 |
| FTE | 1 | 2 | 4 | 5 | 7 | 8 | 8 | 8 | 9 | 9 | 8 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 9 | 8 | 10 | 9 | 8 | 10 | 10 | 10 | 10 | 11 | 10 | 10 | 10 | 11 | 10 | 10 | 11 | 10 | 10 | 11 | 11 | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 | 13 | 13 | 15 | 14 | 14 | 14 | 14 | 14 | 15 | 14 | 14 | 14 | 14 | 14 | 14 | 16 | 16 | 16 | 15 | 17 | 18 | 19 | 17 | 18 | 17 | 19 | 22 | 23 | 23 | 23 | 23 | 23 | 23 | 25 | 25 | 26 | 24 | 25 | 28 | 28 | 26 | 28 | 28 | 28 | 27 | 27 | 27 | 26 | 28 | 29 | 29 | 28 | 27 | 27 | 26 | 25 | 23 | 21 | 17 | 18 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 18 | 18 | 18 | 18 | 17 | 16 | 18 | 19 | 19 | 20 | 20 | 19 | 18 | 20 | 20 | 19 | 19 | 20 | 19 | 20 | 19 | 17 | 18 |
| Series | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 2011 to 2014; quarterly Q3 2010 to Q4 2010; monthly Jan 2015 to Aug 2026.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | -7,806 | -57,917 | -38,920 | -24,035 | -9,158 |
| Operating profit | -29,791 | -84,344 | -64,611 | -40,311 | -25,969 |
| Result for the year | -27,225 | -79,149 | -55,629 | -19,831 | -21,948 |
| Equity | 97,268 | 68,532 | 41,931 | 32,798 | 23,950 |
| Total assets | 106,379 | 91,017 | 50,210 | 57,974 | 43,557 |
| Employees (average) | 21 | 27 | 26 | 17 | 18 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA | -29,196 | -83,805 | -63,882 | -39,552 | -25,292 |
| Employee growth (vækst i antal ansatte) | 31.3% | 28.6% | -3.7% | -34.6% | 5.9% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -21,616 | -73,018 | -35,209 | -42,148 | -31,640 |
| ROIC (afkast af investeret kapital) | -71%note 1 | -184.9%note 1 | -4,504.9%note 1 | n.m.note 2 | n.m.note 2 |
| Capex (investeringer i anlægsaktiver) | 524note 3 | 268note 3 | 1,309note 3 | 568note 3 | 0note 4 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 29 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 26 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 12 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 28 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 4 Jul 2022
Each registered value from the day it took effect, newest first.
From CVR, read 8 Nov 2026. Text such as the signing rule and purpose is shown as registered.
29 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Vedtægter ændret: 27.06.2023
Bestyrelse:
Fratrådte:
Allan Rosetzsky, den 06.10.2022.
Bestyrelse:
Fratrådte:
Gitte Laurette Pedersen-Botero, den 02.06.2021.
Tiltrådte:
Karin Garre, den 02.06.2021, Sara Sande, den 02.06.2021.
Revision:
Fratrådte:
ERNST & YOUNG PARTNERSHIP P/S, den 26.05.2020.
Tiltrådte:
CVR-NR. 30700228 ERNST & YOUNG Godkendt Revisionspartnerselskab, Dirch Passers Allé 36, 2000 Frederiksberg, den 26.05.2020.
Vedtægter ændret: 26.05.2020
Selskabet tegnes af den administrerende direktør eller af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse
Revision:
Fratrådte:
BEIERHOLM, STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 26.05.2020.
Tiltrådte:
CVR-NR. 35683194 ERNST & YOUNG PARTNERSHIP P/S, Dirch Passers Allé 36, 2000 Frederiksberg, den 26.05.2020.
Direktion:
Fratrådte:
Steen Søren Klysner, (adm. dir), den 20.12.2019.
Tiltrådte:
Bent Ulrich Frandsen, (adm. dir), den 20.12.2019.
Vedtægter ændret: 19.12.2016
Kapitalforhøjelsen er besluttet den 19.12.2016.
kr. 2.416,00, indbetalt kontant, kurs 125.788,90. kr. 7.584,00, indbetalt ved konvertering af gæld, kurs 125.788,90.
Kapitalen udgør herefter kr. 530.835,00.
Bestyrelse:
Fratrådte:
Alexander R Duncan, den 24.05.2016.
Tiltrådte:
Charlotte Dyring, den 24.05.2016, Gitte Laurette Pedersen-Botero, den 24.05.2016.
Direktion:
Fratrådte:
Charlotte Dyring, den 24.05.2016.
Vedtægter ændret: 11.12.2015
Vedtægter ændret:
06.12.2012.
Vedtægter ændret:
16.05.2012.
Kapitalforhøjelse:
kr. 67.709,00 indbetalt kontant, kurs 2.400,00.
Kapitalen udgør herefter kr. 520.835,00.
Kapitalen er opdelt i klasser:
A-anparter kr. 250.000,00. B-anparter kr. 270.835,00.
Vedtægter ændret:
19.08.2011.
Kapitalforhøjelse:
kr. 67.709,00 indbetalt kontant, kurs 2.400,00.
Kapitalen udgør herefter kr. 453.126,00.
Kapitalen er opdelt i klasser:
A-anparter kr. 250.000,00. B-anparter kr. 203.126,00.
Ny adresse:
Agern Alle 1, 2970 Hørsholm.
Revision:
Udtrådt af revisionen:
CVR-NR. 12523246 GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 28.01.2011.
Indtrådt i revisionen:
BEIERHOLM, STATSAUTORISERET REVISIONSPARTNERSELSKAB, Gribskovvej 2, 2100 København Ø, den 28.01.2011.
Selskabet tegnes af tre bestyrelsesmedlemmer i forening eller af den samlede bestyrelse eller af en direktør i forening med mindst 2/3 af bestyrelsens medlemmer.
Vedtægter ændret:
16.09.2010.
Kapitalforhøjelse:
kr. 135.417,00 indbetalt kontant, kurs 2.400,00.
Kapitalen udgør herefter kr. 385.417,00.
Kapitalen er opdelt i klasser:
A-anparter kr. 250.000,00, B-anparter kr. 135.417,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Willem Adriaan De Jongh, den 16.09.2010, Charlotte Dyring, den 16.09.2010.
Indtrådt i bestyrelsen:
Direktør Allan Rosetzsky, den 16.09.2010, Martin Welschof, den 16.09.2010.
Vedtægter ændret:
02.07.2010.
Selskabet tegnes af tre bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Vedtægter ændret:
02.07.2010.
Kapitalforhøjelse:
kr. 125.000,00 indbetalt i værdier, kurs 100,00.
Kapitalen udgør herefter kr. 250.000,00.
Vedtægter ændret:
04.03.2010.
Ny adresse:
Fremtidsvej 3, 2970 Hørsholm.
Ny kommune:
Rudersdal.
Vedtægter ændret:
18.02.2010.
Nyt navn:
EXPRES2ION BIOTECHNOLOGIES ApS.
Ny adresse:
c/o Charlotte Dyring, Hannelundsvej 10, 2960 Rungsted Kyst.
Ny kommune:
Hørsholm.
Bestyrelse:
Indtrådt i bestyrelsen:
Martin Roland Jensen (formand), den 18.02.2010, Willem Adriaan De Jongh, den 18.02.2010, Charlotte Dyring, den 18.02.2010.
Direktion:
Udtrådt af direktionen:
Peter Andreas Stakemann, den 18.02.2010.
Indtrådt i direktionen:
Charlotte Dyring, den 18.02.2010.
Selskabet tegnes af 2 medlemmer af bestyrelsen i forening.
Revision:
Indtrådt i revisionen:
CVR-NR. 12523246 GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB, Stockholmsgade 45, 2100 København Ø, den 18.02.2010.
Stiftelsesdato:
01.01.2010.
Seneste vedtægtsdato:
01.01.2010.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
kontant kr. 125.000,00 til kurs 100,00.
Stifter:
CVR-NR. 19270939 ApS KBUS 38 NR. 3117, Kronprinsessegade 18, 1306 København K, den 01.01.2010.
Direktion:
Advokat Peter Andreas Stakemann, den 01.01.2010.
Selskabet tegnes af en direktør.
Første regnskabsår:
01.01.2010 - 31.12.2010.
Regnskabsår:
01.01 - 31.12.
1 registered in CVR.
P-number 1015842969Agern Alle 1, 2970 Hørsholm
No other current company drawn.
No other current company drawn.